JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB206414

Anti-GDF15 antibody [EPR19939]

Be the first to review this product! Submit a review

|

(23 Publications)

Anti-GDF15 antibody [EPR19939] (ab206414) is a rabbit monoclonal antibody detecting GDF15 in Western Blot, IP, IHC-P, ELISA. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

MIC1, PDF, PLAB, PTGFB, GDF15, Growth/differentiation factor 15, GDF-15, Macrophage inhibitory cytokine 1, NSAID-activated gene 1 protein, NSAID-regulated gene 1 protein, Placental TGF-beta, Placental bone morphogenetic protein, Prostate differentiation factor, MIC-1, NAG-1, NRG-1

9 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDF15 antibody [EPR19939] (AB206414)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDF15 antibody [EPR19939] (AB206414)

Immunohistochemical analysis of paraffin-embedded human prostate hyperplasia tissue labeling GDF15 with ab206414 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Cytoplasmic staining on human prostate hyperplasia is observed (PMID : 9593718). Positive staining on human placenta and prostate hyperplasia other tissues tested were negative.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDF15 antibody [EPR19939] (AB206414)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDF15 antibody [EPR19939] (AB206414)

Immunohistochemical analysis of paraffin-embedded human placenta tissue labeling GDF15 with ab206414 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Cytoplasmic staining on human placenta is observed (PMID : 9593718). Positive staining on human placenta and prostate hyperplasia other tissues tested were negative.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDF15 antibody [EPR19939] (AB206414)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDF15 antibody [EPR19939] (AB206414)

Immunohistochemical analysis of formalin fixed paraffin embedded human prostate labelling GDF15 with ab206414 at a concentration of 3µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins. ab206414 anti-GDF15 antibody [EPR19939] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

Immunoprecipitation - Anti-GDF15 antibody [EPR19939] (AB206414)
  • IP

Supplier Data

Immunoprecipitation - Anti-GDF15 antibody [EPR19939] (AB206414)

GDF15 was immunoprecipitated from 0.35 mg of HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate with ab206414 at 1/30 dilution.

Western blot was performed from the immunoprecipitate using ab206414 at 1/1000 dilution.

VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

Lane 1 : HepG2 whole cell lysate 10μg (Input).

Lane 2 : ab206414 IP in HepG2 whole cell lysate.

Lane 3 : Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) instead of ab206414 in HepG2 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 10 seconds.

All lanes:

Immunoprecipitation - Anti-GDF15 antibody [EPR19939] (ab206414)

Predicted band size: 34 kDa

false

Western blot - Anti-GDF15 antibody [EPR19939] (AB206414)
  • WB

Supplier Data

Western blot - Anti-GDF15 antibody [EPR19939] (AB206414)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1 : 10 seconds; Lane 2 : 3 minutes.

The molecular weight observed is consistent with the literature (PMID : 20884666).

All lanes:

Western blot - Anti-GDF15 antibody [EPR19939] (ab206414) at 1/1000 dilution

Lane 1:

Human prostate cancer lysate at 10 µg

Lane 2:

Human placenta lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution

Predicted band size: 34 kDa

Observed band size: 12.5 kDa

false

Western blot - Anti-GDF15 antibody [EPR19939] (AB206414)
  • WB

Unknown

Western blot - Anti-GDF15 antibody [EPR19939] (AB206414)

Blocking/Dilution buffer : 5% NFDM/TBST.

The expression level of GDF15 can be increased by TPA treatment (PMID : 15757899).

All lanes:

Western blot - Anti-GDF15 antibody [EPR19939] (ab206414) at 1/1000 dilution

Lane 1:

Untreated HT1080 (Human fibrosarcoma cell line) whole cell lysate at 10 µg

Lane 2:

HT1080 (Human fibrosarcoma cell line) whole cell lysate treated with 200ng/ml Phorbol-12-myristate-13-acetate (TPA) for 24 hours at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 34 kDa

Observed band size: 35 kDa

false

Exposure time: 3s

Western blot - Anti-GDF15 antibody [EPR19939] (AB206414)
  • WB

Supplier Data

Western blot - Anti-GDF15 antibody [EPR19939] (AB206414)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1 : 3 minutes; Lane 2 : 10 seconds.

The molecular weight observed is consistent with the literature (PMID : 20884666).

All lanes:

Western blot - Anti-GDF15 antibody [EPR19939] (ab206414) at 1/1000 dilution

Lane 1:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

LNCaP (Human prostate cancer cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution

Predicted band size: 34 kDa

Observed band size: 12.5 kDa,35 kDa

false

Western blot - Anti-GDF15 antibody [EPR19939] (AB206414)
  • WB

Supplier Data

Western blot - Anti-GDF15 antibody [EPR19939] (AB206414)

Blocking/Dilution buffer : 5% NFDM/TBST.

Both pro and mature form can be increased by TPA treatment.

All lanes:

Western blot - Anti-GDF15 antibody [EPR19939] (ab206414) at 1/1000 dilution

Lane 1:

Untreated HT1080 (Human fibrosarcoma cell line) whole cell lysate at 10 µg

Lane 2:

HT1080 (Human fibrosarcoma cell line) whole cell lysate treated with 200ng/ml Phorbol-12-myristate-13-acetate (TPA) for 24 hours at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 34 kDa

Observed band size: 35 kDa

false

Exposure time: 1min

ELISA - Anti-GDF15 antibody [EPR19939] (AB206414)
  • ELISA

Lab

ELISA - Anti-GDF15 antibody [EPR19939] (AB206414)

ELISA analysis of ab206414 binding functionally active mature GDF15 (ab50077) at 1 μg/mL.

  • Carrier free

    Anti-GDF15 antibody [EPR19939] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19939

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ELISA, WB, IHC-P, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p>IHC tests show positive staining only on human placenta and prostate hyperplasia tissues, other tissues tested were negative.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-GDF15 antibody [EPR19939] (ab206414) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), ELISA in Human samples.

What is the molecular weight of GDF15?
Anti-GDF15 [EPR19939] (ab206414) specifically detects a band for GDF15 (UniProt: Q99988) at a molecular weight of 34kDa.

Trusted by the scientific community
Anti-GDF15 [EPR19939] (ab206414) was first used in a scientific publication in 2016 and has been cited over 10 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EPR19939] also available for your convenience: ab206414, Carrier free - ab223539, Carrier free - ab271973

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Hormone produced in response to various stresses to confer information about those stresses to the brain, and trigger an aversive response, characterized by nausea, vomiting, and/or loss of appetite (PubMed : 23468844, PubMed : 24971956, PubMed : 28846097, PubMed : 28846098, PubMed : 28846099, PubMed : 28953886, PubMed : 29046435, PubMed : 30639358, PubMed : 31875646, PubMed : 33589633, PubMed : 38092039). The aversive response is both required to reduce continuing exposure to those stresses at the time of exposure and to promote avoidance behavior in the future (PubMed : 30639358, PubMed : 33589633, PubMed : 38092039). Acts by binding to its receptor, GFRAL, activating GFRAL-expressing neurons localized in the area postrema and nucleus tractus solitarius of the brainstem (PubMed : 28846097, PubMed : 28846098, PubMed : 28846099, PubMed : 28953886, PubMed : 31535977). It then triggers the activation of neurons localized within the parabrachial nucleus and central amygdala, which constitutes part of the 'emergency circuit' that shapes responses to stressful conditions (PubMed : 28953886). The GDF15-GFRAL signal induces expression of genes involved in metabolism, such as lipid metabolism in adipose tissues (PubMed : 31402172). Required for avoidance behavior in response to food allergens : induced downstream of mast cell activation to promote aversion and minimize harmful effects of exposure to noxious substances (By similarity). In addition to suppress appetite, also promotes weight loss by enhancing energy expenditure in muscle : acts by increasing calcium futile cycling in muscle (By similarity). Contributes to the effect of metformin, an anti-diabetic drug, on appetite reduction and weight loss : produced in the kidney in response to metformin treatment, thereby activating the GDF15-GFRAL response, leading to reduced appetite and weight (PubMed : 31875646, PubMed : 37060902). The contribution of GDF15 to weight loss following metformin treatment is however limited and subject to discussion (PubMed : 36001956). Produced in response to anticancer drugs, such as camptothecin or cisplatin, promoting nausea, vomiting and contributing to malnutrition (By similarity). Overproduced in many cancers, promoting anorexia in cancer (cachexia) (PubMed : 32661391). Responsible for the risk of nausea and vomiting during pregnancy : high levels of GDF15 during pregnancy, mostly originating from the fetus, are associated with increased nausea and vomiting (PubMed : 38092039). Maternal sensitivity to nausea is probably determined by pre-pregnancy exposure to GDF15, women with naturally high level of GDF15 being less susceptible to nausea than women with low levels of GDF15 before pregnancy (PubMed : 38092039). Promotes metabolic adaptation in response to systemic inflammation caused by bacterial and viral infections in order to promote tissue tolerance and prevent tissue damage (PubMed : 31402172). Required for tissue tolerance in response to myocardial infarction by acting as an inhibitor of leukocyte integring activation, thereby protecting against cardiac rupture (By similarity). Inhibits growth hormone signaling on hepatocytes (By similarity).
See full target information GDF15

Publications (23)

Recent publications for all applications. Explore the full list and refine your search

Redox biology 82:103613 PubMed40174478

2025

Repression of oxidative phosphorylation by NR2F2, MTERF3 and GDF15 in human skin under high-glucose stress.

Applications

Unspecified application

Species

Unspecified reactive species

S Ley-Ngardigal,S Claverol,L Sobilo,M Moreau,C Hubert,J Goupil,A Poulignon,W Mahfouf,H Fatrouni,L Dard,M Juan,L Gales,A Merched,C Tokarski,E Leblanc,A Galinier,D Lacombe,H R Rezvani,F Bellvert,K Pays,C Nizard,N Dias Amoedo,A L Bulteau,R Rossignol

American journal of cancer research 15:452-469 PubMed40084368

2025

GDF15 promotes the resistance of epithelial ovarian cancer cells to gemcitabine via DHCR24-mediated cholesterol metabolism to elevate ABCB1 and ABCC1 levels in lipid rafts.

Applications

Unspecified application

Species

Unspecified reactive species

Linlin Guo,Yan He,Huang Xin

Aging cell 24:e70031 PubMed40025898

2025

Diabetes Advances Cardiomyocyte Senescence Through Interfering Rnd3 Expression and Function.

Applications

Unspecified application

Species

Unspecified reactive species

Linxu Wu,Xinglin Zhu,Shanshan Pan,Yan Chen,Cai Luo,Yangyang Zhao,Jingci Xing,Kaijia Shi,Shuya Zhang,Jiaqi Li,Jinxuan Chai,Xuebin Ling,Jianmin Qiu,Yan Wang,Zhihua Shen,Wei Jie,Junli Guo

Nature communications 15:8690 PubMed39375367

2024

Single-cell RNA sequencing reveals the pro-inflammatory roles of liver-resident Th1-like cells in primary biliary cholangitis.

Applications

Unspecified application

Species

Unspecified reactive species

Ciliang Jin,Penglei Jiang,Zhaoru Zhang,Yingli Han,Xue Wen,Lin Zheng,Wei Kuang,Jiangshan Lian,Guodong Yu,Xinyue Qian,Yue Ren,Miaomiao Lu,Lingling Xu,Weixin Chen,Jiyang Chen,Yuwei Zhou,Jinxia Xin,Ben Wang,Xi Jin,Pengxu Qian,Yida Yang

EMBO molecular medicine 16:2080-2108 PubMed39103698

2024

The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.

Applications

Unspecified application

Species

Unspecified reactive species

Jinhai Deng,Teng Pan,Dan Wang,Yourae Hong,Zaoqu Liu,Xingang Zhou,Zhengwen An,Lifeng Li,Giovanna Alfano,Gang Li,Luigi Dolcetti,Rachel Evans,Jose M Vicencio,Petra Vlckova,Yue Chen,James Monypenny,Camila Araujo De Carvalho Gomes,Gregory Weitsman,Kenrick Ng,Caitlin McCarthy,Xiaoping Yang,Zedong Hu,Joanna C Porter,Christopher J Tape,Mingzhu Yin,Fengxiang Wei,Manuel Rodriguez-Justo,Jin Zhang,Sabine Tejpar,Richard Beatson,Tony Ng

Toxicology research 13:tfae112 PubMed39070057

2024

GDF15 regulated by HDAC2 exerts suppressive effects on oxygen-glucose deprivation/reoxygenation-induced neuronal cell pyroptosis via the NLRP3 inflammasome.

Applications

Unspecified application

Species

Unspecified reactive species

Hua Xiao,Wei Chen,Darong Lu,Guixin Shi,Xiangping Xia,Shengtao Yao

Scientific reports 14:12949 PubMed38839839

2024

Growth/differentiation factor 15 (GDF15) expression in the heart after myocardial infarction and cardioprotective effect of pre-ischemic rGDF15 administration.

Applications

Unspecified application

Species

Unspecified reactive species

Geoffrey Dogon,Eve Rigal,Eliot Potel,Marie Josse,Luc Rochette,Yannick Bejot,Catherine Vergely

Biomolecules 14: PubMed38254638

2024

GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex.

Applications

Unspecified application

Species

Unspecified reactive species

Baikang Xie,Wenjing Tang,Shuang Wen,Fen Chen,Chao Yang,Min Wang,Yong Yang,Wei Liang

Journal of Cancer 15:1115-1123 PubMed38230211

2024

Suppression of malignant melanoma by knocking down growth differentiation factor-15 via inhibiting PTEN/PI3K/AKT signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Zhou,Caifeng Chen

Cell division 18:21 PubMed38082448

2023

Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Dongliang Yang,Zhongyin He,Jiawei Lu,Xiaolin Yuan,Haiyong Liu,Yagang Xue,Ting Chen,Hongxing Gu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com